UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Immunotherapy in hepatocellular carcinoma

Annals of hepatology, 2019-03, Vol.18 (2), p.291-297

2019

Link zum Volltext

Verfügbarkeit prüfen

Lack of shared neoantigens in prevalent mutations in cancer

Journal of translational medicine, 2024-04, Vol.22 (1), p.344-344

2024

Link zum Volltext

Verfügbarkeit prüfen

Molecular mimicry between tumor associated antigens and microbiota-derived epitopes

Journal of translational medicine, 2022-07, Vol.20 (1), p.1-316, Article 316

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular mimicry and cancer vaccine development

Molecular cancer, 2023-04, Vol.22 (1), p.75-75, Article 75

2023

Link zum Volltext

Verfügbarkeit prüfen

Human Endogenous Retrovirus Reactivation: Implications for Cancer Immunotherapy

Cancers, 2021-04, Vol.13 (9), p.1999

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification and characterization of heteroclitic peptides in TCR-binding positions with improved HLA-binding efficacy

Journal of translational medicine, 2021-02, Vol.19 (1), p.89-89, Article 89

2021

Link zum Volltext

Verfügbarkeit prüfen

1331 Cancer vaccine development based on molecular mimicry

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1482-A1482

2023

Link zum Volltext

Verfügbarkeit prüfen

Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case

Journal of translational medicine, 2022-10, Vol.20 (1), p.1-472, Article 472

2022

Link zum Volltext

Verfügbarkeit prüfen

High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy

Cancers, 2019-11, Vol.11 (12), p.1824

2019

Link zum Volltext

Verfügbarkeit prüfen

Cross-reactive CD8 + T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs)

Journal of experimental & clinical cancer research, 2024-03, Vol.43 (1), p.87-87

2024

Link zum Volltext

Verfügbarkeit prüfen

Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides

Journal of translational medicine, 2021-12, Vol.19 (1), p.526-526, Article 526

2021

Link zum Volltext

Verfügbarkeit prüfen

Immunological effects of adjuvants in subsets of antigen presenting cells of cancer patients undergoing chemotherapy

Journal of translational medicine, 2020-01, Vol.18 (1), p.34-34, Article 34

2020

Link zum Volltext

Verfügbarkeit prüfen

MHC-Optimized Peptide Scaffold for Improved Antigen Presentation and Anti-Tumor Response

Frontiers in immunology, 2021-10, Vol.12, p.769799-769799

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs)

Journal for immunotherapy of cancer, 2021-05, Vol.9 (5), p.e002694

2021

Link zum Volltext

Verfügbarkeit prüfen

Novel Molecular Targets for Hepatocellular Carcinoma

Cancers, 2021-12, Vol.14 (1), p.140

2021

Link zum Volltext

Verfügbarkeit prüfen

Neoantigens as potential vaccines in hepatocellular carcinoma

Journal for immunotherapy of cancer, 2022-02, Vol.10 (2), p.e003978

2022

Link zum Volltext

Verfügbarkeit prüfen

Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches

Cancer letters, 2020-03, Vol.473, p.25-32

2020

Link zum Volltext

Verfügbarkeit prüfen

1175 Memory T cells elicited by microorganisms cross-react with tumor-associated antigens

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1218-A1218

2022

Link zum Volltext

Verfügbarkeit prüfen

Microorganisms-derived antigens for preventive anti-cancer vaccines

Molecular aspects of medicine, 2023-08, Vol.92, p.101192-101192, Article 101192

2023

Link zum Volltext

Verfügbarkeit prüfen

High somatic mutation and neoantigen burden do not correlate with decreased progression-free survival in HCC patients

Journal of hepatology, 2020-08, Vol.73, p.S566

2020

Link zum Volltext

Verfügbarkeit prüfen

FRI340 - High somatic mutation and neoantigen burden do not correlate with decreased progression-free survival in HCC patients

Journal of hepatology, 2020-08, Vol.73, p.S566-S566

2020

Link zum Volltext

Verfügbarkeit prüfen

Cross-reactive CD8+ T cell responses to tumor-associated antigens

Journal of experimental & clinical cancer research, 2024-03, Vol.43 (1)

2024

Link zum Volltext

Verfügbarkeit prüfen

FRI476 - Identification of neoantigens as potential vaccines in hepatocellular carcinoma

Journal of hepatology, 2020-08, Vol.73, p.S634-S635

2020

Link zum Volltext

Verfügbarkeit prüfen

Identification of neoantigens as potential vaccines in hepatocellular carcinoma

Journal of hepatology, 2020-08, Vol.73, p.S634-S635

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(23)
Tagungsberichte
(1)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Immunotherapy in hepatocellular carcinoma

Lack of shared neoantigens in prevalent mutations in cancer

Molecular mimicry between tumor associated antigens and microbiota-derived epitopes

Molecular mimicry and cancer vaccine development

Human Endogenous Retrovirus Reactivation: Implications for Cancer Immunotherapy

Identification and characterization of heteroclitic peptides in TCR-binding positions with improved HLA-binding efficacy

1331 Cancer vaccine development based on molecular mimicry

Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case

High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy

Cross-reactive CD8 + T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs)

Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides

Immunological effects of adjuvants in subsets of antigen presenting cells of cancer patients undergoing chemotherapy

MHC-Optimized Peptide Scaffold for Improved Antigen Presentation and Anti-Tumor Response

Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs)

Novel Molecular Targets for Hepatocellular Carcinoma

Neoantigens as potential vaccines in hepatocellular carcinoma

Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches

1175 Memory T cells elicited by microorganisms cross-react with tumor-associated antigens

Microorganisms-derived antigens for preventive anti-cancer vaccines

High somatic mutation and neoantigen burden do not correlate with decreased progression-free survival in HCC patients

FRI340 - High somatic mutation and neoantigen burden do not correlate with decreased progression-free survival in HCC patients

Cross-reactive CD8+ T cell responses to tumor-associated antigens

FRI476 - Identification of neoantigens as potential vaccines in hepatocellular carcinoma

Identification of neoantigens as potential vaccines in hepatocellular carcinoma

Suchergebnisse filtern